AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bestova L 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Letrozole (2.5mg)

Overview Bestova L 2.5mg Tablet

Postmenopausal women with breast cancer may find relief with LetoFem 2.5mg tablets. This medication can be a standalone treatment or used alongside surgery or radiation therapy. It's also employed in advanced breast cancer to hinder metastasis. LetoFem 2.5mg can be taken with or without food, always following your doctor's prescribed dosage and duration for optimal results. Dosage varies depending on the specific application; your physician will tailor the regimen to your needs. Consistent use, as directed, is crucial. Common side effects include increased perspiration, weariness, hot flushes, and elevated cholesterol. Report any concerning side effects to your doctor, who can offer management strategies. Prior to starting LetoFem 2.5mg, disclose any history of kidney or liver problems, or osteoporosis. Inform your doctor of all other medications you're taking, as interactions may impact effectiveness. Pregnancy and breastfeeding should also be reported to your physician. Blood tests to assess vitamin D levels and bone density may be conducted before and during treatment.

Uses of Bestova L 2.5mg Tablet

Managing breast cancer

Major Benefits of Bestova L 2.5mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 2.5mg Bestova L Tablet whole; do not crush, chew, or divide it. While it can be taken with or without food, consistent timing is recommended.

Common Side effects of Bestova L 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Bestova L 2.5mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Bestova L 2.5mg Tablets can be administered with or without food, though consistent timing is recommended.

How Bestova L 2.5mg Tablet works:

Estrogen production is reduced by Bestova L 2.5mg Tablets, an aromatase inhibitor. This lowered estrogen level inhibits the growth of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Ingesting alcohol alongside Bestova L 2.5mg Tablet presents no known adverse reactions.

PregnancyPregnancyUNSAFE

Use of Bestova L 2.5mg Tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; animal and human studies indicate substantial risks to fetal development.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Bestova L 2.5mg Tablets due to potential infant toxicity.

DrivingDrivingUNSAFE

Taking Bestova L 2.5mg Tablets may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving is inadvisable if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Use of the 2.5mg Bestova L Tablet is considered safe for individuals with kidney disease, and no dosage modification is typically advised. Nevertheless, data regarding its use in patients experiencing end-stage renal disease is scarce. Physician consultation is recommended.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Bestova L 2.5mg tablets. Dosage modification of Bestova L 2.5mg tablets may be necessary. Physician consultation is advised.

What if you forget to take Bestova L 2.5mg Tablet :

Should you forget a Bestova L 2.5mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Bestova L 2.5mg Tablet

LabelValue
Type of Compound Benzophenone-related compound
Potential for Dependence None.
Medication Category Cancer therapeutics

FAQs on Bestova L 2.5mg Tablet

Aromatase inhibitor Bestova L 2.5mg tablets are typically used in postmenopausal women with breast cancer, following menopause, surgery, or chemotherapy.
The medication Bestova L 2.5mg Tablet functions as an aromatase inhibitor, a type of anti-estrogen agent. Its mechanism involves suppressing estrogen synthesis by inhibiting aromatase, the enzyme responsible for estrogen production. Estrogen fuels the growth of certain breast cancers, termed "estrogen-receptor-positive" cancers. Lowering estrogen levels can therefore hinder tumor development.
For advanced breast cancer or cancer that has metastasized, continued Bestova L 2.5mg Tablet use is advised until tumor progression is observed. Following tamoxifen therapy or surgery, a five-year course of Bestova L 2.5mg Tablets is recommended, ceasing treatment upon tumor recurrence if that occurs sooner. Alternatively, a sequential regimen is possible: two years of Bestova L 2.5mg Tablets followed by three years of tamoxifen.
Concurrent use of irbesartan and Bestova L 2.5mg tablets is permissible. Nevertheless, diligent blood pressure monitoring is advised, as Bestova L 2.5mg tablets can elevate blood pressure. Seek medical advice if blood pressure management proves challenging.
While rare, Bestova L 2.5mg Tablets may induce cataract formation. Therefore, report any blurred vision or eye discomfort to your physician promptly.
Experiencing hot flashes may indicate a common side effect of Bestova L 2.5mg Tablet, resulting from lowered estrogen levels. These episodes often lessen as your body adapts to the medication. Nevertheless, some individuals might experience persistent hot flashes and night sweats throughout treatment, subsiding only after several months post-treatment. If this side effect is significantly disruptive, a physician can offer appropriate management strategies.
Serious adverse reactions are uncommon, affecting only a small percentage of patients. Potential severe side effects associated with Bestova L 2.5mg Tablet are stroke, angina pectoris, myocardial infarction, thromboembolic events, cataracts, osteoporosis, and severe cutaneous reactions.
Taking Bestova L 2.5mg Tablets can lead to bone thinning or loss (osteoporosis) resulting from reduced estrogen. Your physician might assess your bone mineral density—a method for detecting osteoporosis—before, throughout, and following the treatment period.
The Ministry of Health and Family Welfare designates Bestova L 2.5mg Tablets solely for inducing ovulation in women with anovulatory infertility.
Bestova L 2.5mg Tablet
133
MRP 155
14% off